Business ❯Pharmaceutical Industry

Drug Pricing

Market Regulation Drug Importation Safety Protocols U.S.-China Relations Trade Relations Drug Approval HIV Patient Advocacy Prescription Drug Costs Protests

FDA Approves Twice-Yearly Lenacapavir Injection for HIV Prevention

High list prices threaten to limit uptake under looming Medicaid cuts alongside HIV prevention budget reductions

FDA Ends GLP-1 Drug Shortages, Triggering New Pricing and Coverage Moves

Trump Administration’s Planned 25% Tariffs on Pharmaceuticals Expected to Raise U.S. Drug Costs by $51 Billion Annually

Eli Lilly Expands Zepbound Access with New Doses and Lower Prices

Trump Repeals Biden-Era Order on Prescription Drug Pricing